We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

20 hedge funds and large institutions have $413K invested in VIVEVE MED INC in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

11% more funds holding

Funds holding: 18 → 20 (+2)

38% less capital invested

Capital invested by funds: $665K → $413K (-$252K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$21.9K
2
VF
Virtu Financial
New York
+$19.1K
3
TSS
Two Sigma Securities
New York
+$13K
4
UBS Group
UBS Group
Switzerland
+$8.38K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.35K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$25.2K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$24K
3
E
Ergoteles
New York
-$18K
4
Millennium Management
Millennium Management
New York
-$2.31K
5
Citigroup
Citigroup
New York
-$726

VIVE Hedge Fund Activity: Q2 2022 in Review

20 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2022, worth a combined $413K — down 38% from $665K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new VIVE positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.9K. The largest seller was Renaissance Technologies, cutting an estimated $25.2K.

  • 20 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2022, up from 18 in Q1 2022.
  • Funds reported $413K of VIVEVE MED INC stock for Q2 2022, down 38% quarter-over-quarter.
  • 5 funds opened new VIVEVE MED INC positions in Q2 2022 and 3 closed out, a net change of +2 holders.
  • The largest VIVEVE MED INC buyer in Q2 2022 was Citadel Advisors, an estimated $21.9K added.
  • The largest VIVEVE MED INC seller in Q2 2022 was Renaissance Technologies, an estimated $25.2K sold.

Based on aggregated 13F filings for Q2 2022.